Elanco Animal Health Incorporated (ELAN) — Fair Value Analysis
Base-case fair value (P50): $17.84 · Current price: $24.05 · Verdict: Overvalued
The Verdict on ELAN
Our Monte Carlo simulations indicate ELANCO ANIMAL HEALTH INC (ELAN) is currently Fairly Valued. The stock trades at $24.05, while our median fair value (P50) stands at $17.84. This assessment suggests the market price is largely in line with its intrinsic value, implying a modest -25.8% when compared to our P50 estimate. For investors, this narrow margin between the current price and our probabilistic fair value suggests limited immediate arbitrage opportunities based on our base case. The simulation, run across thousands of forward scenarios, anchors ELAN's valuation firmly near its present market level, reflecting a balanced risk/reward profile at $24.05.
How ELAN stacks up against peers
ELAN's operational and financial health is categorized as "average" when benchmarked against its sector peers. This "average" quality tier suggests the company exhibits neither significant competitive advantages nor glaring weaknesses compared to its industry cohort. An average quality rating, coupled with a median fair value of $17.84 that is close to the $24.05, reinforces the "Fairly Valued" verdict. This indicates ELAN is performing in line with expectations for a company of its standing, without the premium typically associated with top-tier operational efficiency or the discount applied to underperforming assets. The -25.8% reflects this balanced competitive landscape.
What this means for investors
Given ELAN's "Fairly Valued" status and an "average" quality tier, investors should approach ELANCO ANIMAL HEALTH INC with an understanding of its current market equilibrium. The close proximity of $24.05 to our $17.84 median fair value, alongside a -25.8%, points to a stock where significant fundamental re-rating may require a material shift in business outlook or financial performance. While the base case suggests equilibrium, more aggressive bull or bear scenarios are also explored by our models. To gain a complete perspective on ELAN, including the full bear (P10) and bull (P90) distribution from our Monte Carlo simulations and to track ELAN's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is ELAN overvalued or undervalued right now?
Based on our Monte Carlo simulations, ELAN is currently considered Fairly Valued, as its current price of $24.05 is closely aligned with our median fair value (P50) of $17.84.
What is the bear case and bull case for ELAN?
The full Monte Carlo distribution, including the bear (P10) and bull (P90) price targets, as well as the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate ELAN's fair value?
FairCurve calculates ELAN's fair value using sophisticated Monte Carlo simulations, running thousands of forward scenarios to generate a probabilistic range of intrinsic values.
How can I track ELAN's fair value as it changes?
You can add ELAN to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts when new earnings or significant fundamental data are released.